Carcinoembryonic antigen to detect hepatic metastases of colorectal cancers

Surgery Today

Volumn 33, Issue 8, 2003, Pages 590-594

  Kutun, Suat ^a,b   Celik, Alper ^a   Hatiboglu, Celal ^a   Ulucanlar, Haluk ^a   Cetin, Abdullah ^a  

^a ANKARA ONCOLOGY HOSPITAL   (Turkey)

^b Ankara Onkoloji Hastanesi   (Turkey)

Author keywords

Carcinoembryonic antigen; Colorectal cancer; Hepatic metastasis

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; ARTICLE; BILE LEVEL; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; LIVER METASTASIS; MALE; MESENTERIC VEIN; PERIOPERATIVE PERIOD; PERIPHERAL VEIN; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME; VENOUS BLOOD;

BILE; CARCINOEMBRYONIC ANTIGEN; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0043204586     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00595-003-2546-y     Document Type: Article

References (31)

1. Cooper GS, Yuan Z, Landefeld CS, Johanson JF, Rimm AA. A national population-based study of colorectal cancer and age. Cancer 1995;75:775-81.
2. Levin B. Colorectal cancer screening. Cancer Suppl 1993;72:1056-9.
3. Yeatman TJ, Bland KI, Copeland EM, Hollenback JI, Souba WW, Vogel SB, et al. Relationship between colorectal liver metastases and CEA levels in gallbladder bile. Ann Surg 1989;210:505-12.
4. Poon MA, O'Connell MJ, Wicand HS, Krook JE, Gerstner JB, Tschetter LK. Biochemical modulation of fluorouracil with leucovorin confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. J Clin Oncol 1991;9:1967-72.
5. Cotman J, Marvin L. Colon and rectal surgery. Illustrated by Lois Barnes. 3rd ed. Philadelphia: Lippincott: 1993. p. 487-96.
6. Taylor I, Machin D, Mullee M, Trotter G, Cooke T, West C. A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer. Br J Surg 1985;72:359-63.
7. Gianola FJ, Dwver A, Jones E, Sugerbaker PH. Prospective studies of laboratory and radiologic tests in the management of colon and rectal cancer patients. Dis Colon Rectum 1984;27:811-8.
8. Finlay IG, McArdle CS. Occult hepatic metastases in colorectal carcinoma. Br J Surg 1986;73:732-5.
9. Cohen AM, Minsky BD, Schilsky RL. Colon cancer In: De Vita, VT, editor. Cancer. 4th ed. Philadelphia: Lippincott: 1993. p. 929-78.
10. Norton JA. Carcinoembryonic antigen. Ann Surg 1991;213:95-7.
11. Tabuchi Y, Deguchi H, Imanishi K, Satioh Y. Carcinoembryonic antigen levels of peripheral and draining venous blood in patients with colorectal cancer. Cancer 1992;69:211-7.
12. Hohenbberger P, Schlag PM, Gerneth T, Herfarth C. Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Ann Surg 1994;219:135-43.
13. Ditzel H, Rasmussen JW, Christensen PB, Erb K, Jensenius JC, Phil D. Immunoscintigraphy of colon cancers with the human monoclonal antibody COU-1. Cancer 1994;73:858-63.
14. AJCC/UICC staging classification. Modified from American Joint Commitee on Cancer. Manual for staging of cancer. 3rd ed. Philedelphia: Lippincott; 1988.
15. Union Internationale Centre le Cancer. TNM Classification of Malignant Tumors. 4th ed. Geneva: UICC; 1987.
16. Steele G Jr, Ravikumar TS. Resection of hepatic metastases from colorectal cancer. Ann Surg 1989;210:127-38.
17. Falcone A, Pfanner E, Cianci C, Danesi R, Brunetti I Tacca MD, et al. Suramin in patients with metastatic coloractal cancerpretreated with fluoropyrimidine-based chemotherapy. Cancer 1995;75:440-3.
18. Aigner K, Walther H, Tonn J, Wenzl A, Hechtel R, Merker G, et al. First experimental and clinical results of isolated liver perfusion with cytotoxics in metastases from colorectal primary. Recent Res Cancer Res 1983;86:99-103.
19. Skibba JL, Quebbemen EJ, Komorowski RA, Thorsen KM. Clinical results of hyperthermic liver perfusion for cancer in the liver. Contr Oncol 1988;29:222-8.
20. Mayer A, Takimoto M, Fritz E, Schellander G, Kofler K, Ludwig H. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor and Mdr gene expression in colorectal cancer. Cancer 1993;71:2454-60.
21. Williams NN. Flow cytometry and prognostic implications in patients with solid tumors. Surg Gynecol Obstet. 1990;171:25-7.
22. Bottger TC, Potratz D, Stöckle M, Wellek S, Klupp J, Junginger T. Prognostic value of DNA analysis in colorectal carcinoma. Cancer 1993;72:3579-87.
23. Ding SF, Delhanty JDA, Zografos G, Michail NE, Duoley JS, Habib NA. Chromosome allele loss in colorectal liver metastases and its association with clinical features. Br J Surg 1994;81:875-8.
24. Leen E, Angerson WJ, Warren HW, O'Gormon P, Moule B, Carter EC, et al. Improved sensitivity of colour Doppler flow imaging of colorectal hepatic metastases using galactose microparticles: a preliminary report. Br J Surg 1994;81:252-4.
25. Kaprowski H, Herlyn M, Steplewize Z, et al. Specific antigen in serum of patients with colon cancer. Science 1981;212:53-8.
26. Doerr RJ, Abdel NH, Merchant B. Indium 111 2CE-025 immunoscintigraphy in occult recurrent colorectal cancer with elevated carcinoembryonic antigen level. Arch Surg 1990;125: 226-9.
27. Sinicrope FA, Hart J, Brasitus TA, Michelassi F, Lee J, Safa AR. Relationship of P-Glycoprotein and carcinoembryonic antigen expression in human colon carcinoma to local invasion, DNAploidy, and disease relapse. Cancer 1994;74:2908-16.
28. Ueda T, Furui J, Komuta K, Yamaguchi J, Yamamoto M, Furukawa K, et al. Detection of carcinoembryonic antigen mRNA in the mesenteric vein of patients with resectable colorectal cancer. Surg Today 1998;28:701-6.
29. Ishida H, Yoshinaga K, Gonda T, Ando M, Hojo I, Fukunari H, et al. Biliary carcinoembryonic antigen levels can predict metachronous liver metastases of colorectal cancer. Anticancer Res 2000;20:523-6.
30. Frikart L, Fournier K, Mach JP, Givel JC. Potential value of biliary CEA assay in early detection of colorectal adenocarcinoma liver metastases. Eur J Surg Oncol 1995;21:276-9.
31. Marinus AP, Visse JV, Mulder C, Blomjous JGAM, VanKamp GJ, Cuesta MA, et al. Detection of occult liver metastases by measurement of biliary carcinoembryonic antigen concentrations. Eur J Surg 1996;162:483-8.